Biodesix names James Jett new chief medical officer
BOULDER -- Biodesix, Inc . announced the appointment of internationally recognized lung cancer expert James Jett , M.D., as chief medical officer. Dr. Jett joins Steven Springmeyer , M.D.... Read More
Wednesday October 16, 2019 0 comments
Biodesix issued new patent for improved blood specimen collection device
BOULDER -- Biodesix, Inc . announced it has been issued U.S. Patent Number 10,422,729, which covers the Biodesix Collection Device (BCD). The new device offers improved ease-of-use in blood... Read More
Friday October 4, 2019 0 comments
Biodesix appoints Robert Georgantas senior VP
BOULDER -- Biodesix, Inc . announced the appointment of Robert W. Georgantas III, Ph.D., as the companys senior vice president of research and translational science. Georgantas research... Read More
Wednesday August 14, 2019 0 comments
Biodesix and Immodulon enter R&D partnership to fight pancreatic cancer
BOULDER -- Biodesix Inc. and London-based Immodulon Therapeutics Limited, announced they have entered into a biomarker research collaboration. The partnership will focus on the analysis of... Read More
Tuesday July 30, 2019 0 comments
Biodesix partners with Thermo Fisher Scientific on blood-based cancer test
BOULDER -- Biodesix, Inc , a leader in blood-based lung cancer diagnostic solutions, announced it has entered into an agreement with Thermo Fisher Scientific designed to bring a blood-based... Read More
Wednesday July 10, 2019 0 comments
Biodesix and MRM Proteomics partner to develop precision lung cancer diagnostics
BOULDER-- Biodesix and Canada-based MRM Proteomics Inc. announced they will partner to create novel assays to answer critical clinical questions within the lung cancer continuum of care. ... Read More
Tuesday January 29, 2019 0 comments
Summit: Precision medicine holds key to less costly, more effective cancer diagnosis and treatment
By Steve Porter LOVELAND Theres a new approach to treating cancer and other diseases that aims to be less costly and more effective than traditional methods. Its called precision... Read More
Monday August 1, 2016 0 comments
Biodesix: New clinical findings show diagnostic advances for novel drug
BOULDER -- Biodesix Inc . announced new clinical findings that show its novel investigational test, BDX008 based on profiling serum proteins identifies patients with advanced melanoma who are... Read More
Tuesday November 10, 2015 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
